Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy

被引：0
|
作者：
Cormack, J [1 ]
机构：
[1] Flinders Med Ctr, Div Med Imaging, Bedford Pk, SA 5042, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1998年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：442 / 442
页数：1
相关论文
共 50 条
  • [41] The pituitary uptake of 111In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas
    A. Colao
    S. Lastoria
    D. Ferone
    P. Varrella
    P. Marzullo
    R. Pivonello
    G. Cerbone
    W. Acampa
    M. Salvatore
    G. Lombardi
    Journal of Endocrinological Investigation, 1999, 22 : 176 - 183
  • [42] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]- AND [I-123-TYR(3)]-OCTREOTIDE - THE ROTTERDAM EXPERIENCE WITH MORE THAN 1000 PATIENTS
    KRENNING, EP
    KWEKKEBOOM, DJ
    BAKKER, WH
    BREEMAN, WAP
    KOOIJ, PPM
    OEI, HY
    VANHAGEN, M
    POSTEMA, PTE
    DEJONG, M
    REUBI, JC
    VISSER, TJ
    REIJS, AEM
    HOFLAND, LJ
    KOPER, JW
    LAMBERTS, SWJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (08): : 716 - 731
  • [43] Therapeutic efficacy and toxicity of In-111-DTPA-D-Phe-octreotide in patients with advanced neuroendocrine tumors.
    Schipper, ML
    Gotthardt, M
    Behe, M
    Arnold, R
    Behr, TM
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 137P - 137P
  • [44] Adrenal glands imaging with indium-111-DTPA-D-Phe(1)-octreotide following ACTH therapy
    Lorberboym, M
    Rubin, P
    Warner, R
    Machac, J
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (09) : 1489 - 1491
  • [45] SOMATOSTATIN RECEPTORS IN MENINGIOMAS - A SCINTIGRAPHIC STUDY USING IN-111 DTPA-D-PHE-1-OCTREOTIDE
    MAINI, CL
    TOFANI, A
    SCIUTO, R
    CARAPELLA, C
    CIOFFI, R
    CRECCO, M
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (07) : 550 - 558
  • [46] Biokinetics of 111In-DTPA-D-Phe1-octreotide in nude mice transplanted with a human carcinoid tumor
    Bernhardt, P
    Kölby, L
    Johanson, V
    Benjegård, SA
    Nilsson, O
    Ahlman, H
    Forssell-Aronsson, E
    NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (01) : 67 - 73
  • [47] Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-l-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide
    Krenning, E. P.
    Bakker, W. H.
    Kooij, P. P. M.
    Breeman, W. A. P.
    Oei, H. Y.
    de Jong, M.
    Reubi, J. C.
    Visser, T. J.
    Bruns, C.
    Kwekkeboom, D. J.
    Reijs, A. E. M.
    van Hagen, P. M.
    Koper, J. W.
    Lamberts, S. W. J.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 123S - 129S
  • [48] Treatment with high dose [111In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors -: Evaluation of therapeutic and toxic effects
    Janson, ET
    Eriksson, B
    Öberg, K
    Skogseid, B
    Öhrvall, U
    Nilsson, S
    Westlin, JE
    ACTA ONCOLOGICA, 1999, 38 (03) : 373 - 377
  • [49] Peptide receptor radionuclide therapy with [indium-111-DTPA-D-PHE]-octreotide (OC).
    Krenning, EP
    Valkema, R
    Kooij, PPM
    Breeman, WAP
    Bakker, WH
    deHerder, WW
    vanEijck, CHJ
    Kwekkeboom, DJ
    deJong, M
    Pauwels, S
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 167 - 167
  • [50] Treatment with high dose [111In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors - evaluation of therapeutic and toxic effects
    Janson, Eva Tiensuu
    Eriksson, Barbro
    Oberg, Kjell
    Skogseid, Britt
    Ohrvall, Ulf
    Nilsson, Sten
    Westlin, Jan-Erik
    Acta Oncologica, 38 (03): : 373 - 377
12345